215 related articles for article (PubMed ID: 16917845)
1. An investigation into the in vivo performance variability of pH responsive polymers for ileo-colonic drug delivery using gamma scintigraphy in humans.
Ibekwe VC; Liu F; Fadda HM; Khela MK; Evans DF; Parsons GE; Basit AW
J Pharm Sci; 2006 Dec; 95(12):2760-6. PubMed ID: 16917845
[TBL] [Abstract][Full Text] [Related]
2. A novel coating concept for ileo-colonic drug targeting: proof of concept in humans using scintigraphy.
Varum FJ; Hatton GB; Freire AC; Basit AW
Eur J Pharm Biopharm; 2013 Aug; 84(3):573-7. PubMed ID: 23348235
[TBL] [Abstract][Full Text] [Related]
3. A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery.
Ibekwe VC; Fadda HM; Parsons GE; Basit AW
Int J Pharm; 2006 Feb; 308(1-2):52-60. PubMed ID: 16356670
[TBL] [Abstract][Full Text] [Related]
4. A novel double-coating approach for improved pH-triggered delivery to the ileo-colonic region of the gastrointestinal tract.
Liu F; Moreno P; Basit AW
Eur J Pharm Biopharm; 2010 Feb; 74(2):311-5. PubMed ID: 19932177
[TBL] [Abstract][Full Text] [Related]
5. Interplay between intestinal pH, transit time and feed status on the in vivo performance of pH responsive ileo-colonic release systems.
Ibekwe VC; Fadda HM; McConnell EL; Khela MK; Evans DF; Basit AW
Pharm Res; 2008 Aug; 25(8):1828-35. PubMed ID: 18465212
[TBL] [Abstract][Full Text] [Related]
6. Accelerating the dissolution of enteric coatings in the upper small intestine: evolution of a novel pH 5.6 bicarbonate buffer system to assess drug release.
Varum FJ; Merchant HA; Goyanes A; Assi P; Zboranová V; Basit AW
Int J Pharm; 2014 Jul; 468(1-2):172-7. PubMed ID: 24727141
[TBL] [Abstract][Full Text] [Related]
7. A paradigm shift in enteric coating: achieving rapid release in the proximal small intestine of man.
Liu F; Basit AW
J Control Release; 2010 Oct; 147(2):242-5. PubMed ID: 20655342
[TBL] [Abstract][Full Text] [Related]
8. Characterization of norfloxacine release from tablet coated with a new pH-sensitive polymer, P-4135F.
Hu Z; Shimokawa T; Ohno T; Kimura G; Mawatari SS; Kamitsuna M; Yoshikawa Y; Masuda S; Takada K
J Drug Target; 1999; 7(3):223-32. PubMed ID: 10680978
[TBL] [Abstract][Full Text] [Related]
9. Enteric coated HPMC capsules designed to achieve intestinal targeting.
Cole ET; Scott RA; Connor AL; Wilding IR; Petereit HU; Schminke C; Beckert T; Cadé D
Int J Pharm; 2002 Jan; 231(1):83-95. PubMed ID: 11719017
[TBL] [Abstract][Full Text] [Related]
10. A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers. I. Manipulation Of drug release using Eudragit L100-55 and Eudragit S100 combinations.
Khan MZ; Prebeg Z; Kurjaković N
J Control Release; 1999 Mar; 58(2):215-22. PubMed ID: 10053194
[TBL] [Abstract][Full Text] [Related]
11. A new concept in colonic drug targeting: a combined pH-responsive and bacterially-triggered drug delivery technology.
Ibekwe VC; Khela MK; Evans DF; Basit AW
Aliment Pharmacol Ther; 2008 Oct; 28(7):911-6. PubMed ID: 18647282
[TBL] [Abstract][Full Text] [Related]
12. Colonic release and reduced intestinal tissue damage of coated tablets containing naproxen inclusion complex.
Piao ZZ; Lee MK; Lee BJ
Int J Pharm; 2008 Feb; 350(1-2):205-11. PubMed ID: 17928177
[TBL] [Abstract][Full Text] [Related]
13. Coated hard capsules as the pH-dependent drug transport systems to ileo-colonic compartment.
Dvořáčková K; Rabišková M; Muselík J; Gajdziok J; Bajerová M
Drug Dev Ind Pharm; 2011 Oct; 37(10):1131-40. PubMed ID: 21417619
[TBL] [Abstract][Full Text] [Related]
14. Mucoadhesive platforms for targeted delivery to the colon.
Varum FJ; Veiga F; Sousa JS; Basit AW
Int J Pharm; 2011 Nov; 420(1):11-9. PubMed ID: 21856393
[TBL] [Abstract][Full Text] [Related]
15. Neutron activation based gamma scintigraphic evaluation of enteric-coated capsules for local treatment in colon.
Marvola T; Marvola J; Kanerva H; Ahonen A; Lindevall K; Marvola M
Int J Pharm; 2008 Feb; 349(1-2):24-9. PubMed ID: 17869037
[TBL] [Abstract][Full Text] [Related]
16. Formulation and evaluation of a pulsatile drug delivery system using time- and pH-dependant polymers.
Kadam VD; Gattani SG
Pharm Dev Technol; 2010; 15(1):57-63. PubMed ID: 19552544
[TBL] [Abstract][Full Text] [Related]
17. Colon-specific delivery tablets of sodium 4-aminosalicylic acid.
Li Y; Li HJ; Yang GR; Gu WP; Ma YK; Zhang MH; Sun J; Sun SJ
Yao Xue Xue Bao; 2006 Oct; 41(10):927-32. PubMed ID: 17184108
[TBL] [Abstract][Full Text] [Related]
18. Predicting the gastrointestinal behaviour of modified-release products: utility of a novel dynamic dissolution test apparatus involving the use of bicarbonate buffers.
Merchant HA; Goyanes A; Parashar N; Basit AW
Int J Pharm; 2014 Nov; 475(1-2):585-91. PubMed ID: 25195730
[TBL] [Abstract][Full Text] [Related]
19. Coated capsules for drug targeting to proximal and distal part of human intestine.
Dvorácková K; Rabisková M; Gajdziok J; Vetchý D; Muselík J; Bernatoniene J; Bajerová M; Drottnerová P
Acta Pol Pharm; 2010; 67(2):191-9. PubMed ID: 20369797
[TBL] [Abstract][Full Text] [Related]
20. A pH-dependent colon-targeted oral drug delivery system using methacrylic acid copolymers. II. Manipulation of drug release using Eudragit L100 and Eudragit S100 combinations.
Khan MZ; Stedul HP; Kurjaković N
Drug Dev Ind Pharm; 2000 May; 26(5):549-54. PubMed ID: 10789067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
